UNSPSC 85503815: Supplement upper artery with autologous tissue substitute, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement upper artery with autologous tissue substitute, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 03UY47Z

UNSPSC 85503815 Supplement upper artery with autologous tissue substitute, percutaneous endoscopic approach is a Commodity code that shows little relevant recent activity aligned with its clinical procedure scope. The recent state and local opportunities tagged under this code reflect administrative health services, occupational medicine, pharmacy benefit management, and clinical staffing — none of which involve vascular surgical procedures or tissue-substitute implants. The Phoenix Fire Pension Board and Phoenix Police Pension Board RFP (RTMRFP26001, due October 16, 2026) solicits independent medical evaluation services for disability benefit determinations; the Washington State Department of Transportation RFP (RFP20260825, due October 9, 2026) requests occupational medical surveillance by board-certified occupational physicians; the County of Santa Clara Health System RFP (RFSQHHSFY270052, due October 7, 2026) establishes a qualified vendor pool for temporary ancillary clinical staffing including audiology, radiology, and therapy services; and Collier County's RFP (25-8414, due April 9, 2026) covers pharmacy benefit management. Harris County Juvenile Probation Department issued an RFI for specialty medical services for detained youth (071626BNM, due September 25, 2026), and the City of Long Beach posted an RFP for surgical procedure carve-out benefits through Centers of Excellence (HR26753, due October 7, 2026), but neither directly procures tissue-substitute implant procedures.

The issuing bodies in the recent-opportunity set span state departments (Washington State Department of Transportation), county health systems (Santa Clara, Harris County, Collier County), city retirement boards (Phoenix), and municipal health benefits programs (Long Beach), with activity concentrated in California, Arizona, Washington, and Texas. The code's nominal scope—vascular surgery with autologous tissue—does not match the administrative, occupational-health, and benefits-administration work being solicited. Firms pursuing this code should verify that state and local procurement offices are actually buying vascular implant services or tissue-substitute procedures under this taxonomy before investing in business development effort; the current opportunity set does not support procurement in the clinical domain the code nominally describes.